Analyze Diet

Pharmacokinetics, stability, and retrospective analysis of use of an oral gel formulation of the bovine injectable enrofloxacin in horses.

Abstract: In many cases of equine infectious disease, long-term administration of antimicrobial drugs is required. Oral agents are preferred because of the relative ease of administration compared with other routes. Enrofloxacin has been shown to be effective against a variety of equine pathogens, but oral administration of this drug has proved difficult in horses. An oral gel formulation made from the injectable cattle product produces blood levels sufficient to resolve infections caused by a variety of common equine pathogens.
Publication Date: 2004-10-07 PubMed ID: 15468012
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article
  • Randomized Controlled Trial
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the effectiveness of an oral gel formulation of the antibiotic enrofloxacin, usually administered via injection in cows, in treating equine infections. The study found that this formulation achieves sufficient blood levels in horses and resolves infections caused by various common pathogens.

Pharmacokinetics and Stability of the Formulation

  • The pharmacokinetics of a medication reflects how the body absorbs, distributes, metabolizes, and excretes the drug. This study confirmed that the oral gel formulation of enrofloxacin made from the injectable bovine product is well absorbed and maintained in the horses’ bodies at levels sufficient to fight off infection.
  • The stability of an oral gel formulation is essential for its storage, transport, and ultimately, the delivery of the intended dose to the patient. The formulation was tested for its physical and chemical stability, as well as its ability to maintain its effectiveness over time. The study concludes that the oral gel formulation remains stable and retains its medicinal properties.

Retrospective Analysis of Use

  • Retrospective analysis of the use of the oral gel formulation in horses provides real-world evidence of its efficacy against common equine pathogens. This type of analysis looks at past data or records to assess the outcomes associated with the use of the new formulation.
  • The analysis showed positive results, with the formulation resolving the infections in horses. This confirms that not only does the formulation ensure sufficient delivery of the medicine into the bloodstream, but it also works effectively to treat the infections for which it was intended.

Implications for Treatment of Equine Diseases

  • Long-term treatment with antibiotics is often needed to fully address equine infections. The study’s findings suggest that the oral gel formulation of enrofloxacin is an effective treatment option, likely improving adherence to treatment due to its ease of administration.
  • The research potentially paves the way for more extensive use of this oral gel formulation in equine healthcare. This could make the process of medicating horses easier, more efficient, and perhaps more effective in combatting a variety of infections.

Cite This Article

APA
Epstein K, Cohen N, Boothe D, Nieuwoudt C, Chandler J. (2004). Pharmacokinetics, stability, and retrospective analysis of use of an oral gel formulation of the bovine injectable enrofloxacin in horses. Vet Ther, 5(2), 155-167.

Publication

ISSN: 1528-3593
NlmUniqueID: 100936368
Country: United States
Language: English
Volume: 5
Issue: 2
Pages: 155-167

Researcher Affiliations

Epstein, Kira
  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania, Kennett Square, PA, USA.
Cohen, Noah
    Boothe, Dawn
      Nieuwoudt, Cornelia
        Chandler, Jeff

          MeSH Terms

          • Absorption
          • Administration, Oral
          • Animals
          • Anti-Infective Agents / administration & dosage
          • Anti-Infective Agents / pharmacokinetics
          • Anti-Infective Agents / therapeutic use
          • Antineoplastic Agents / administration & dosage
          • Antineoplastic Agents / pharmacokinetics
          • Antineoplastic Agents / therapeutic use
          • Area Under Curve
          • Bacterial Infections / drug therapy
          • Bacterial Infections / veterinary
          • Biological Availability
          • Cross-Over Studies
          • Enrofloxacin
          • Female
          • Fluoroquinolones / administration & dosage
          • Fluoroquinolones / pharmacokinetics
          • Fluoroquinolones / therapeutic use
          • Gels
          • Horse Diseases / drug therapy
          • Horses
          • Male
          • Quinolones / administration & dosage
          • Quinolones / pharmacokinetics
          • Quinolones / therapeutic use
          • Retrospective Studies
          • Temperature
          • Treatment Outcome

          Citations

          This article has been cited 1 times.
          1. Rhodes DM, Magdesian KG, Byrne BA, Kass PH, Edman J, Spier SJ. Minimum inhibitory concentrations of equine Corynebacterium pseudotuberculosis isolates (1996-2012).. J Vet Intern Med 2015 Jan;29(1):327-32.
            doi: 10.1111/jvim.12534pubmed: 25586790google scholar: lookup